| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on sale of alphazyme | - | 0 | - | - |
| Total other income (expense), net | -50,643 | -64,706 | -25,104 | -846 |
| Net loss | -1,976,012 | -1,793,774 | -2,027,579 | -203,460 |
| Basic net loss per common share | -0.06 | -0.06 | -0.07 | -0.01 |
| Diluted net loss per common share | -0.06 | -0.06 | - | - |
| Diluted weighted-average common shares outstanding | 34,507,530 | 30,102,324 | - | - |
DYADIC INTERNATIONAL INC (DYAI)
DYADIC INTERNATIONAL INC (DYAI)